Similar articles

• Paget's disease. Common cause of bone weakening.

  [No authors listed] [No authors listed] Mayo Clin Health Lett. 2013 Jun;31(6):7. Mayo Clin Health Lett. 2013. PMID: 24716278 No abstract available.
• [Zoledronic acid efficacy in Paget's disease of bone: a three-year experience].

  Conesa Mateos A, Rotés Sala D, Almirall Bernabé M, Carbonell Abelló J. Conesa Mateos A, et al. Med Clin (Barc). 2006 Oct 28;127(16):635-6. doi: 10.1157/13094423. Med Clin (Barc). 2006. PMID: 17145033 Spanish. No abstract available.
• The physical therapist's leg pain: Paget's disease.

  Carlsen D, Hassan TS, Lewi JE. Carlsen D, et al. Am J Med. 2015 Feb;128(2):130-2. doi: 10.1016/j.amjmed.2014.10.020. Epub 2014 Oct 19. Am J Med. 2015. PMID: 25448177 No abstract available.
• A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.

  Abelson A. Abelson A. Curr Med Res Opin. 2008 Mar;24(3):695-705. doi: 10.1185/030079908X260899. Epub 2008 Jan 25. Curr Med Res Opin. 2008. PMID: 18226324 Review.
• Clinical practice. Paget's disease of bone.

  Whyte MP. Whyte MP. N Engl J Med. 2006 Aug 10;355(6):593-600. doi: 10.1056/NEJMcp060278. N Engl J Med. 2006. PMID: 16899779 Review. No abstract available.